Literature DB >> 21196119

Transient restoration of succinate dehydrogenase activity after rhabdomyolysis in iron-sulphur cluster deficiency myopathy.

Gittan Kollberg1, Atle Melberg, Elisabeth Holme, Anders Oldfors.   

Abstract

Myopathy with exercise intolerance and deficiency of iron-sulphur cluster proteins is caused by an intronic IVS5+382 G>C mutation in ISCU, the gene encoding the iron-sulphur cluster assembly protein (IscU). The mutation causes alternative splicing resulting in a truncated protein and severely reduced levels of IscU protein in muscle tissue. Disease manifestations include muscle fatigability, dyspnoea, cardiac palpitations and episodic myoglobinuria. Muscle tissue of these patients demonstrates marked histochemical succinate dehydrogenase deficiency and accumulation of iron in muscle fibres, which are morphological hallmarks of the disease. A biopsy specimen from a patient, two months after a severe attack of rhabdomyolysis, revealed regenerating muscle with normal succinate dehydrogenase activity and only minor iron accumulation, whereas another biopsy obtained nine years after the episode showed the typical hallmarks of the disease. The apparent explanation for the normal succinate dehydrogenase activity during regeneration was a markedly increased level of IscU protein in regenerating muscle tissue and an increase in normally spliced ISCU transcripts in the patient. The results have implications for diagnosis of the disease based on muscle biopsy findings and support the concept that an increase of normally spliced ISCU by RNA modulating therapy may be a therapeutic possibility for these patients. Copyright Â
© 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21196119     DOI: 10.1016/j.nmd.2010.11.010

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  10 in total

Review 1.  Synthesis, delivery and regulation of eukaryotic heme and Fe-S cluster cofactors.

Authors:  Dulmini P Barupala; Stephen P Dzul; Pamela Jo Riggs-Gelasco; Timothy L Stemmler
Journal:  Arch Biochem Biophys       Date:  2016-01-16       Impact factor: 4.013

Review 2.  Metabolic Myoglobinuria.

Authors:  Emanuele Barca; Valentina Emmanuele; Salvatore Billi DiMauro
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

3.  Tissue specificity of a human mitochondrial disease: differentiation-enhanced mis-splicing of the Fe-S scaffold gene ISCU renders patient cells more sensitive to oxidative stress in ISCU myopathy.

Authors:  Daniel R Crooks; Suh Young Jeong; Wing-Hang Tong; Manik C Ghosh; Hayden Olivierre; Ronald G Haller; Tracey A Rouault
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

4.  The presence of multiple cellular defects associated with a novel G50E iron-sulfur cluster scaffold protein (ISCU) mutation leads to development of mitochondrial myopathy.

Authors:  Prasenjit Prasad Saha; S K Praveen Kumar; Shubhi Srivastava; Devanjan Sinha; Gautam Pareek; Patrick D'Silva
Journal:  J Biol Chem       Date:  2014-02-26       Impact factor: 5.157

Review 5.  Iron-sulfur cluster biogenesis in mammalian cells: New insights into the molecular mechanisms of cluster delivery.

Authors:  Nunziata Maio; Tracey A Rouault
Journal:  Biochim Biophys Acta       Date:  2014-09-19

6.  Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle.

Authors:  Daniel R Crooks; Thanemozhi G Natarajan; Suh Young Jeong; Chuming Chen; Sun Young Park; Hongzhan Huang; Manik C Ghosh; Wing-Hang Tong; Ronald G Haller; Cathy Wu; Tracey A Rouault
Journal:  Hum Mol Genet       Date:  2013-08-13       Impact factor: 6.150

Review 7.  Rhabdomyolysis: a genetic perspective.

Authors:  Renata Siciliani Scalco; Alice R Gardiner; Robert Ds Pitceathly; Edmar Zanoteli; Jefferson Becker; Janice L Holton; Henry Houlden; Heinz Jungbluth; Ros Quinlivan
Journal:  Orphanet J Rare Dis       Date:  2015-05-02       Impact factor: 4.123

8.  FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis With Distinct Severity and Iron Regulation.

Authors:  Sebastian Montealegre; Elise Lebigot; Hugo Debruge; Norma Romero; Bénédicte Héron; Pauline Gaignard; Antoine Legendre; Apolline Imbard; Stéphanie Gobin; Emmanuelle Lacène; Patrick Nusbaum; Arnaud Hubas; Isabelle Desguerre; Aude Servais; Pascal Laforêt; Peter van Endert; François Jérome Authier; Cyril Gitiaux; Pascale de Lonlay
Journal:  Neurol Genet       Date:  2022-01-19

9.  Regulation of iron homeostasis by the p53-ISCU pathway.

Authors:  Yuki Funauchi; Chizu Tanikawa; Paulisally Hau Yi Lo; Jinichi Mori; Yataro Daigo; Atsushi Takano; Yohei Miyagi; Atsushi Okawa; Yusuke Nakamura; Koichi Matsuda
Journal:  Sci Rep       Date:  2015-11-12       Impact factor: 4.379

10.  PTBP1 acts as a dominant repressor of the aberrant tissue-specific splicing of ISCU in hereditary myopathy with lactic acidosis.

Authors:  Denise F R Rawcliffe; Lennart Österman; Angelica Nordin; Monica Holmberg
Journal:  Mol Genet Genomic Med       Date:  2018-09-12       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.